TipRanks
Northwest Biotherapeutics (DE:NBYB)
STUTTGART:NBYB
Germany Market
NBYB
Northwest Biotherapeutics
RESEARCH TOOLSreports

Northwest Biotherapeutics (NBYB) Income Statement

0 Followers

Northwest Biotherapeutics Income Statement

Last quarter (Q2 2026), Northwest Biotherapeutics's total revenue was $807.00K, an increase of 516.03% from the same quarter last year. In Q2, Northwest Biotherapeutics's net income was $-9.22M. See Northwest Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.38M$ 1.38M$ 1.93M$ 1.68M$ 1.00M
Gross Profit
$ -959.00K$ 1.38M$ -25.80M$ 135.00K$ -19.30M
Operating Expenses
$ 58.95M$ 67.89M$ 57.44M$ 68.86M$ 53.71M
Depreciation and Amortization
$ 2.34M$ 2.04M$ 1.73M$ 1.50M$ 586.00K
EBITDA
$ -49.67M$ -73.64M$ -55.34M$ -97.46M$ 184.72M
Operating Income
$ -59.91M$ -66.51M$ -55.51M$ -67.18M$ -52.70M
Other Income/Expenses
$ -785.00K$ -17.27M$ -7.09M$ -37.85M$ 231.83M
Pretax Income
$ -60.70M$ -83.78M$ -62.60M$ -105.03M$ 179.13M
Net Income
$ -61.48M$ -83.78M$ -62.60M$ -105.03M$ 179.13M
Per Share Metrics
Basic EPS
$ -0.04$ -0.07$ -0.06$ -0.10$ 0.21
Diluted EPS
$ -0.04$ -0.07$ -0.06$ -0.10$ -0.06
Weighted Average Shares Outstanding
 1.46B 1.24B 1.12B 1.02B 873.52M
Weighted Average Shares Outstanding (Diluted)
 1.46B 1.24B 1.12B 1.02B 1.01B
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History